Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 28 | 2022 | 1056 | 2.640 |
Why?
|
| Heart Transplantation | 13 | 2022 | 904 | 1.350 |
Why?
|
| Heart, Artificial | 6 | 2018 | 69 | 1.340 |
Why?
|
| Heart Failure | 18 | 2022 | 2500 | 1.220 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 414 | 0.750 |
Why?
|
| Models, Cardiovascular | 3 | 2018 | 190 | 0.740 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 560 | 0.520 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 316 | 0.420 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2005 | 226 | 0.400 |
Why?
|
| Assisted Circulation | 2 | 2014 | 39 | 0.370 |
Why?
|
| Thrombosis | 3 | 2014 | 755 | 0.350 |
Why?
|
| Heart Ventricles | 4 | 2017 | 847 | 0.340 |
Why?
|
| Prosthesis Design | 6 | 2019 | 663 | 0.330 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2008 | 102 | 0.320 |
Why?
|
| Pulsatile Flow | 4 | 2016 | 143 | 0.300 |
Why?
|
| Plasma Exchange | 1 | 2008 | 103 | 0.280 |
Why?
|
| Myocardium | 4 | 2018 | 1251 | 0.280 |
Why?
|
| Pulse | 1 | 2006 | 38 | 0.280 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2005 | 70 | 0.260 |
Why?
|
| Transplantation, Heterotopic | 2 | 2014 | 44 | 0.230 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 329 | 0.230 |
Why?
|
| Jehovah's Witnesses | 1 | 2023 | 23 | 0.220 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2010 | 1163 | 0.210 |
Why?
|
| Bioprosthesis | 3 | 2018 | 131 | 0.210 |
Why?
|
| Aorta | 1 | 2006 | 683 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 434 | 0.200 |
Why?
|
| Preoperative Care | 1 | 2008 | 1552 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 219 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1613 | 0.170 |
Why?
|
| Bioartificial Organs | 1 | 2018 | 9 | 0.160 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2019 | 56 | 0.160 |
Why?
|
| Materials Testing | 1 | 2018 | 119 | 0.150 |
Why?
|
| Hemodynamics | 4 | 2016 | 973 | 0.150 |
Why?
|
| Treatment Outcome | 13 | 2022 | 33863 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 152 | 0.150 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 132 | 0.150 |
Why?
|
| Anemia | 1 | 2023 | 730 | 0.140 |
Why?
|
| Male | 27 | 2022 | 128957 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2018 | 256 | 0.130 |
Why?
|
| Middle Aged | 21 | 2019 | 90395 | 0.130 |
Why?
|
| Equipment Design | 4 | 2016 | 1207 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 534 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 244 | 0.130 |
Why?
|
| Hemorheology | 1 | 2015 | 39 | 0.130 |
Why?
|
| Humans | 35 | 2023 | 271884 | 0.130 |
Why?
|
| Cattle | 4 | 2018 | 846 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 117 | 0.120 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 45 | 0.120 |
Why?
|
| Aged | 16 | 2019 | 73471 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2014 | 181 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 710 | 0.110 |
Why?
|
| Female | 23 | 2022 | 149143 | 0.100 |
Why?
|
| Adult | 21 | 2022 | 81857 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 782 | 0.100 |
Why?
|
| Thromboembolism | 2 | 2010 | 153 | 0.100 |
Why?
|
| Survival Rate | 4 | 2019 | 12533 | 0.100 |
Why?
|
| Hemorrhage | 2 | 2013 | 747 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2012 | 691 | 0.100 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 580 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1781 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2014 | 560 | 0.090 |
Why?
|
| Time Factors | 5 | 2010 | 13130 | 0.090 |
Why?
|
| Stroke | 3 | 2013 | 1094 | 0.090 |
Why?
|
| Miniaturization | 1 | 2009 | 49 | 0.080 |
Why?
|
| Transposition of Great Vessels | 1 | 2010 | 131 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2009 | 85 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 441 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2022 | 39780 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2008 | 19 | 0.080 |
Why?
|
| Bleeding Time | 1 | 2008 | 12 | 0.080 |
Why?
|
| Prothrombin Time | 1 | 2008 | 42 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2013 | 9491 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2008 | 53 | 0.080 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 239 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2009 | 218 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1327 | 0.070 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 138 | 0.070 |
Why?
|
| Bilirubin | 1 | 2008 | 224 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 485 | 0.070 |
Why?
|
| Sheep | 1 | 2006 | 273 | 0.070 |
Why?
|
| Cause of Death | 2 | 2009 | 787 | 0.070 |
Why?
|
| Creatinine | 1 | 2008 | 546 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 394 | 0.060 |
Why?
|
| Brachiocephalic Trunk | 1 | 2005 | 39 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 75 | 0.060 |
Why?
|
| United States | 5 | 2022 | 16050 | 0.060 |
Why?
|
| Hemolysis | 2 | 2018 | 127 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 6986 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 543 | 0.060 |
Why?
|
| Blood Transfusion | 2 | 2023 | 583 | 0.060 |
Why?
|
| Young Adult | 6 | 2013 | 22108 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2015 | 1436 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 792 | 0.060 |
Why?
|
| Adolescent | 8 | 2013 | 32663 | 0.050 |
Why?
|
| Caveolins | 1 | 2003 | 79 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 2 | 2003 | 327 | 0.050 |
Why?
|
| Device Removal | 1 | 2005 | 338 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2017 | 5690 | 0.050 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 89 | 0.050 |
Why?
|
| Heart | 2 | 2014 | 1214 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2005 | 3646 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 228 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2010 | 9325 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 566 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 31042 | 0.040 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 201 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 280 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2003 | 484 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 62807 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 5118 | 0.040 |
Why?
|
| Quality of Life | 4 | 2022 | 4749 | 0.040 |
Why?
|
| Outpatients | 2 | 2013 | 469 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2018 | 100 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 946 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 4399 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 3072 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1104 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10259 | 0.040 |
Why?
|
| Biopsy | 1 | 2005 | 3544 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 701 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 739 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 247 | 0.030 |
Why?
|
| Benchmarking | 1 | 2018 | 284 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 188 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 195 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 1041 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2015 | 21 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 141 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1610 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 107 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 3689 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2014 | 215 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 98 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2002 | 2383 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 264 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 203 | 0.030 |
Why?
|
| Child | 4 | 2022 | 30492 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 227 | 0.030 |
Why?
|
| Biomarkers | 1 | 2005 | 5112 | 0.030 |
Why?
|
| Calcineurin | 1 | 2014 | 131 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 192 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 349 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 1047 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 380 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 676 | 0.020 |
Why?
|
| Retreatment | 1 | 2012 | 447 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 898 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 123 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2009 | 170 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2009 | 48 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 113 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 291 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 1572 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 835 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 152 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1313 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 262 | 0.020 |
Why?
|
| Software | 1 | 2014 | 1385 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 330 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 578 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 13400 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 392 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 3651 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 2250 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 15267 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 152 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5840 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1402 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 5520 | 0.010 |
Why?
|
| Caveolin 2 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Caveolin 3 | 1 | 2003 | 15 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1983 | 51 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 2864 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2003 | 53 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 758 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 887 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 2002 | 23 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 265 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 4199 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2002 | 26 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 1155 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 206 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 568 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 1074 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 605 | 0.010 |
Why?
|
| Calcinosis | 1 | 1983 | 432 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6270 | 0.010 |
Why?
|
| Palliative Care | 1 | 2010 | 2159 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1983 | 401 | 0.010 |
Why?
|
| Critical Care | 1 | 2005 | 810 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 18045 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 5195 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 2457 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 12222 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 3417 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6489 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 36041 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 6883 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 7822 | 0.010 |
Why?
|